Editorial reveals strategies to enhance cancer immunotherapy by monitoring the immune/tumor microenvironment, suggesting advanced imaging and AI tools.
Key Points
This editorial highlights the importance of monitoring the immune/tumor microenvironment to enhance cancer immunotherapy outcomes.
Key mechanisms and technologies include advanced imaging techniques that allow real-time visualization of immune responses and cellular interactions.
Emerging biomarkers, like tertiary lymphoid structures, play critical roles in predicting therapeutic responses in various cancers.
Harnessing artificial intelligence for data fusion can improve the accuracy of predictive models related to immunotherapy outcomes.